HIV Citation List: December 20, 2013 - January 2, 2014

PubMed citations

1. Effects of Alpha Interferon Treatment on Intrinsic anti-HIV-1 Immunity in Vivo.Abdel-Mohsen, M., X. Deng, T. Liegler, J.C. Guatelli, M.S. Salama, D. Ghanem Hel, A. Rauch, B. Ledergerber, S.G. Deeks, H.F. Gunthard, J.K. Wong, and S.K. Pillai. Journal of Virology, 2014. 88(1): p. 763-767. PMID[24155399].

[PubMed]. HIV_1220-010214.

2. Activity of and Effect of Subcutaneous Treatment with the Broad-spectrum Antiviral Lectin Griffithsin in Two Laboratory Rodent Models. Barton, C., J.C. Kouokam, A.B. Lasnik, O. Foreman, A. Cambon, G. Brock, D.C. Montefiori, F. Vojdani, A.A. McCormick, B.R. O'Keefe, and K.E. Palmer. Antimicrobial Agents and Chemotherapy, 2014. 58(1): p. 120-127. PMID[24145548].

[PubMed]. HIV_1220-010214.

3. Discovery of Novel Ribonucleoside Analogs with Activity against Human Immunodeficiency Virus Type 1. Dapp, M.J., L. Bonnac, S.E. Patterson, and L.M. Mansky. Journal of Virology, 2014. 88(1): p. 354-363. PMID[24155391].

[PubMed]. HIV_1220-010214.

4. Kinase Control of Latent HIV-1 Infection: PIM-1 Kinase as a Major Contributor to HIV-1 Reactivation. Duverger, A., F. Wolschendorf, J.C. Anderson, F. Wagner, A. Bosque, T. Shishido, J. Jones, V. Planelles, C. Willey, R.Q. Cron, and O. Kutsch. Journal of Virology, 2014. 88(1): p. 364-376. PMID[24155393].

[PubMed]. HIV_1220-010214.

5. Nano-NRTIs Demonstrate Low Neurotoxicity and High Antiviral Activity against HIV Infection in the Brain. Gerson, T., E. Makarov, T.H. Senanayake, S. Gorantla, L.Y. Poluektova, and S.V. Vinogradov. Nanomedicine, 2014. 10(1): p. 177-185. PMID[23845925].

[PubMed]. HIV_1220-010214.

6. Development and in Vitro Evaluation of a Vaginal Microbicide Gel Formulation for UAMC01398, a Novel Diaryltriazine NNRTI against HIV-1. Grammen, C., K.K. Arien, M. Venkatraj, J. Joossens, P. Van der Veken, J. Heeres, P.J. Lewi, S. Haenen, K. Augustyns, G. Vanham, P. Augustijns, and J. Brouwers. Antiviral Research, 2014. 101: p. 113-121. PMID[24269474].

[PubMed]. HIV_1220-010214.

7. GS-8374, a Prototype Phosphonate-containing Inhibitor of HIV-1 Protease, Effectively Inhibits Protease Mutants with Amino acid Insertions.Grantz Saskova, K., M. Kozisek, K. Stray, D. de Jong, P. Rezacova, J. Brynda, N.M. van Maarseveen, M. Nijhuis, T. Cihlar, and J. Konvalinka. Journal of Virology, 2013. [Epub ahead of print]. PMID[24371077].

[PubMed]. HIV_1220-010214.

8. Novel Neuroprotective GSK-3beta Inhibitor Restricts Tat-mediated HIV-1 Replication.Guendel, I., S. Iordanskiy, R. Van Duyne, K. Kehn-Hall, M. Saifuddin, R. Das, E. Jaworski, G.C. Sampey, S. Senina, L. Shultz, A. Narayanan, H. Chen, B. Lepene, C. Zeng, and F. Kashanchi. Journal of Virology, 2014. 88(2): p. 1189-1208. PMID[24227837].

[PubMed]. HIV_1220-010214.

9. Enantioselective Inhibition of Reverse Transcriptase (RT) of HIV-1 by Non-racemic Indole-based Trifluoropropanoates Developed by Asymmetric Catalysis Using Recyclable Organocatalysts. Han, X., W. Ouyang, B. Liu, W. Wang, P. Tien, S. Wu, and H.B. Zhou. Organic & Biomolecular Chemistry, 2013. 11(48): p. 8463-8475. PMID[24202207].

[PubMed]. HIV_1220-010214.

10. In Vitro Characterization of MK-1439: A Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor. Lai, M.T., M. Feng, J.P. Falgueyret, P. Tawa, M. Witmer, D. Distefano, Y. Li, J. Burch, N. Sachs, M. Lu, E. Cauchon, L.C. Campeau, J. Grobler, Y. Yan, Y. Ducharme, B. Cote, E. Asante-Appiah, D.J. Hazuda, and M.D. Miller. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[24379202].

[PubMed]. HIV_1220-010214.

11. Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Cross-resistance: Implications for Preclinical Evaluation of Novel NNRTIs and Clinical Genotypic Resistance Testing. Melikian, G.L., S.Y. Rhee, V. Varghese, D. Porter, K. White, J. Taylor, W. Towner, P. Troia, J. Burack, E. Dejesus, G.K. Robbins, K. Razzeca, R. Kagan, T.F. Liu, W.J. Fessel, D. Israelski, and R.W. Shafer. The Journal of Antimicrobial Chemotherapy, 2014. 69(1): p. 12-20. PMID[23934770].

[PubMed]. HIV_1220-010214.

12. Protective Effect of Vaginal Application of Neutralizing and Nonneutralizing Inhibitory Antibodies against Vaginal SHIV Challenge in Macaques.Moog, C., N. Dereuddre-Bosquet, J.L. Teillaud, M.E. Biedma, V. Holl, G. Van Ham, L. Heyndrickx, A. Van Dorsselaer, D. Katinger, B. Vcelar, S. Zolla-Pazner, I. Mangeot, C. Kelly, R.J. Shattock, and R. Le Grand. Mucosal Immunology, 2014. 7(1): p. 46-56. PMID[23591718].

[PubMed]. HIV_1220-010214.

13. Synthesis, anti-HIV Activity, Integrase Enzyme Inhibition and Molecular Modeling of Catechol, Hydroquinone and Quinol Labdane Analogs. Pawar, R., T. Das, S. Mishra, Nutan, B. Pancholi, S.K. Gupta, and S.V. Bhat. Bioorganic & Medicinal Chemistry Letters, 2014. 24(1): p. 302-307. PMID[24291042].

[PubMed]. HIV_1220-010214.

14. The Tyrosine Kinase Inhibitor Dasatinib Blocks in-Vitro HIV-1 Production by Primary CD4+ T Cells from HIV-1 Infected Patients.Pogliaghi, M., L. Papagno, S. Lambert, R. Calin, V. Calvez, C. Katlama, and B. Autran. AIDS, 2013. [Epub ahead of print]. PMID[24361684].

[PubMed]. HIV_1220-010214.

15. Unique Characteristics of Histone Deacetylase Inhibitors in Reactivation of Latent HIV-1 in Bcl-2-transduced Primary Resting CD4+ T Cells.Shan, L., S. Xing, H.C. Yang, H. Zhang, J.B. Margolick, and R.F. Siliciano. The Journal of Antimicrobial Chemotherapy, 2014. 69(1): p. 28-33. PMID[23999005]. [PubMed]. HIV_1220-010214.

16. HIV Cell Fusion Assay: Phenotypic Screening Tool for the Identification of HIV Entry Inhibitors via CXCR4. Smith, E.B., R.A. Ogert, D. Pechter, A. Villafania, S.J. Abbondanzo, K. Lin, A. Rivera-Gines, C. Rebsch-Mastykarz, and F.J. Monsma, Jr. Journal of Biomolecular Screening, 2014. 19(1): p. 108-118. PMID[23989454].

[PubMed]. HIV_1220-010214.

17. Anti-HIV-1 Integrase Activity of Mimusops elengi Leaf Extracts.Suedee, A., S. Tewtrakul, and P. Panichayupakaranant. Pharmaceutical Biology, 2014. 52(1): p. 58-61. PMID[24033292].

[PubMed]. HIV_1220-010214.

18. The Innate Immune Factor Apolipoprotein L1 Restricts HIV-1 Infection.Taylor, H.E., A.K. Khatua, and W. Popik. Journal of Virology, 2014. 88(1): p. 592-603. PMID[24173214]. [PubMed]. HIV_1220-010214.

19. Anti-HIV-1 Activities of Extracts and Phenolics from Smilax china L.Wang, W.X., J.Y. Qian, X.J. Wang, A.P. Jiang, and A.Q. Jia. Pakistan Journal of Pharmaceutical Sciences, 2014. 27(1): p. 147-151. PMID[24374442].

[PubMed]. HIV_1220-010214.

20. 10E8-like Neutralizing Antibodies against HIV-1 Induced Using a Precisely Designed Conformational Peptide as a Vaccine Prime. Yu, Y., P. Tong, Y. Li, Z. Lu, and Y. Chen. Science China. Life Sciences, 2013. [Epub ahead of print]. PMID[24369352].

[PubMed]. HIV_1220-010214.

21. A Novel Modified Peptide Derived from Membrane-proximal External Region of Human Immunodeficiency Virus Type 1 Envelope Significantly Enhances Retrovirus Infection.Zhang, L., C. Jiang, H. Zhang, X. Gong, L. Yang, L. Miao, Y. Shi, Y. Zhang, W. Kong, C. Zhang, and Y. Shan. Journal of Peptide Science, 2014. 20(1): p. 46-54. PMID[24254845].

[PubMed]. HIV_1220-010214.

22. Design, Synthesis and Preliminary SAR Studies of Novel N-Arylmethyl Substituted Piperidine-linked Aniline Derivatives as Potent HIV-1 NNRTIs.Zhang, L., P. Zhan, X. Chen, Z. Li, Z. Xie, T. Zhao, H. Liu, E. De Clercq, C. Pannecouque, J. Balzarini, and X. Liu. Bioorganic & Medicinal Chemistry, 2014. 22(1): p. 633-642. PMID[24275349].

[PubMed]. HIV_1220-010214.

23. A Novel Ribonuclease with Antiproliferative Activity toward Leukemia and Lymphoma Cells and HIV-1 Reverse Transcriptase Inhibitory Activity from the Mushroom, Hohenbuehelia serotina. Zhang, R., L. Zhao, H. Wang, and T.B. Ng. International Journal of Molecular Medicine, 2014. 33(1): p. 209-214. PMID[24220107].

[PubMed]. HIV_1220-010214.

ISI Web of Knowledge Citations

24. Pyrimidine-5-carbonitriles - Part III: Synthesis and Antimicrobial Activity of Novel 6-(2-Substituted propyl)-2,4-disubstituted pyrimidine-5-carbonitriles. Al-Deeb, O.A., A.A. Al-Turkistani, E.S. Al-Abdullah, N.R. El-Brollosy, E.E. Habib, and A.A. El-Emam. Heterocyclic Communications, 2013. 19(6): p. 411-419. ISI[000327716800006].

[WOS]. HIV_1220-010214.

25. Synthesis of 3,4-Disubstituted quinolin-2-(1H)-ones via Palladium-catalyzed Decarboxylative Arylation Reactions. Carrer, A., J.D. Brion, S. Messaoudi, and M. Alami. Advanced Synthesis & Catalysis, 2013. 355(10): p. 2044-2054. ISI[000327814900021].

[WOS]. HIV_1220-010214.

26. Novel Piperidinylamino-diarylpyrimidine Derivatives with Dual Structural Conformations as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors.Chen, X.W., X. Liu, Q. Meng, D. Wanga, H.Q. Liu, E. De Clercq, C. Pannecouque, J. Balzarini, and X.Y. Liu. Bioorganic & Medicinal Chemistry Letters, 2013. 23(24): p. 6593-6597. ISI[000327787700013].

[WOS]. HIV_1220-010214.

27. New Scaffolds of Natural Origin as Integrase LEDGF/P75 Interaction Inhibitors: Virtual Screening and Activity Assays. De Luca, L., F. Morreale, F. Christ, Z. Debyser, S. Ferro, and R. Gitto. European Journal of Medicinal Chemistry, 2013. 68: p. 405-411. ISI[000326902300042].

[WOS]. HIV_1220-010214.

28. Cycloartanes from the Gum Resin of Gardenia gummifera L.F.Gandhe, S., S. Lakavath, S. Palatheeya, W. Schuehly, K. Amancha, R.K.R. Nallamaddi, A. Palepu, Y. Thakur, V. Belvotagi, R.K. Bobbala, V. Achanta, and O. Kunert. Chemistry & Biodiversity, 2013. 10(9): p. 1613-1622. ISI[000327863400006].

[WOS]. HIV_1220-010214.

29. Parthenium hysterophorus: A Probable Source of Anticancer, Antioxidant and anti-HIV Agents. Kumar, S., G. Chashoo, A.K. Saxena, and A.K. Pandey. Biomed Research International, 2013. 810734: p. 11. ISI[000327655100001].

[WOS]. HIV_1220-010214.

30. Microwave-and Ultrasound-assisted Synthesis of Some Acyclonucleobases Based on a Uracil Moiety Using DMAP as Base. Lahsasni, S.A. Nucleosides Nucleotides & Nucleic Acids, 2013. 32(8): p. 439-452. ISI[000327945200003].

[WOS]. HIV_1220-010214.

31. Structure-Activity Relationship Studies of the Aromatic Positions in Cyclopentapeptide CXCR4 Antagonists. Mungalpara, J., Z.G. Zachariassen, S. Thiele, M.M. Rosenkilde, and J. Vabeno. Organic & Biomolecular Chemistry, 2013. 11(47): p. 8202-8208. ISI[000327908500009].

[WOS]. HIV_1220-010214.

32. Extracts from Acacia catechu Suppress HIV-1 Replication by Inhibiting the Activities of the Viral Protease and Tat. Nutan, M. Modi, C.S. Dezzutti, S. Kulshreshtha, A.K.S. Rawat, S.K. Srivastava, S. Malhotra, A. Verma, U. Ranga, and S.K. Gupta. Virology Journal, 2013. 10. ISI[000327875700002].

[WOS]. HIV_1220-010214.

33. Natural Stilbenoids Isolated from Grapevine Exhibiting Inhibitory Effects against HIV-1 Integrase and Eukaryote MOS1 Transposase in Vitro Activities.Pflieger, A., P.W. Teguo, Y. Papastamoulis, S. Chaignepain, F. Subra, S. Munir, O. Delelis, P. Lesbats, C. Calmels, M.L. Andreola, J.M. Merillon, C. Auge-Gouillou, and V. Parissi. PloS One, 2013. 8(11): p. e81184. ISI[000327657900025].

[WOS]. HIV_1220-010214.

34. Efficient Synthesis of 5'-0(N)-Carbamyl and -Polycarbamyl Nucleosides.Shelton, J.R. and M.A. Peterson. Tetrahedron Letters, 2013. 54(50): p. 6882-6885. ISI[000327285300021].

[WOS]. HIV_1220-010214.

35. An Engineered HIV-1 gp41 Trimeric Coiled Coil with Increased Stability and anti-HIV-1 Activity: Implication for Developing anti-HIV Microbicides.Tong, P., Z.F. Lu, X. Chen, Q. Wang, F. Yu, P. Zou, X.X. Yu, Y. Li, L. Lu, Y.H. Chen, and S.B. Jiang. Journal of Antimicrobial Chemotherapy, 2013. 68(11): p. 2533-2544. ISI[000326978600020].

[WOS]. HIV_1220-010214.

36. Characterization of Structure, Dynamics, and Detergent Interactions of the anti-HIV Chemokine Variant 5P12-RANTES.Wiktor, M., O. Hartley, and S. Grzesiek. Biophysical Journal, 2013. 105(11): p. 2586-2597. ISI[000327940400016].

[WOS]. HIV_1220-010214.

37. Synthesis and anti-HIV Activity of a Series of 6-Modified 2',3'-Dideoxyguanosine and 2',3'-Didehydro-2',3'-dideoxyguanosine Analogs. Xie, L.J., X.T. Yang, D.L. Pan, Y.L. Cao, M. Cao, G.C. Lin, Z. Guan, Y. Guo, L.H. Zhang, and Z.J. Yang. Chinese Journal of Chemistry, 2013. 31(9): p. 1207-1218. ISI[000327882900013].

[WOS]. HIV_1220-010214.

38. Synthesis and Biological Evaluation of 2,6-Dichloropurine Bicyclonucleosides Containing a Triazolyl-carbohydrate Moiety. Zhang, Q.R., P. He, G.Q. Zhou, Y.F. Gu, T. Fu, D.Q. Xue, and H.M. Liu. Carbohydrate Research, 2013. 382: p. 65-70. ISI[000327491700010].

[WOS]. HIV_1220-010214.

39. DB-02, a C-6-Cyclohexylmethyl Substituted Pyrimidinone HIV-1 Reverse Transcriptase Inhibitor with Nanomolar Activity, Displays an Improved Sensitivity against K103N or Y181C Than S-DABOs. Zhang, X.J., L.H. Lu, R.R. Wang, Y.P. Wang, R.H. Luo, C.C. Lai, L.M. Yang, Y.P. He, and Y.T. Zheng. PloS one, 2013. 8(11): p. e81489. ISI[000327543500102].

[WOS]. HIV_1220-010214.

Patent Citations

40. Preparation of Β-Hairpin Peptidomimetics as CXCR4 Antagonists for Treatment of HIV Infection. Gombert, F.O., D. Obrecht, A. Lederer, J. Zimmermann, and C. Oefner. Patent. 2013. 2012-EP60766 2013182240: 48pp.

[Patent]. HIV_1220-010214.

41. Preparation of Thiosemicarbazone Iron Chelators as HIV-1 Inhibitors. Nekhai, S. and D.B. Kovalskyy. Patent. 2013. 2013-US31231 2013169361: 58pp.

[Patent]. HIV_1220-010214.